Methylphenidate use in children with attention deficit hyperactivity disorder.

Area of Science:

• Pharmacology
• Public Health
• Evidence-Based Medicine

Background:

• A Brazilian Health Technology Assessment Bulletin (BRATS) article on methylphenidate for attention deficit hyperactivity disorder (ADHD) has generated controversy.
• The BRATS article's methodology and conclusions regarding ADHD treatment are under scrutiny.
• Critical review is necessary due to the BRATS' relevance for public health decisions in Brazil.

Purpose of the Study:

• To critically review the methodology and findings of the BRATS article on methylphenidate for ADHD.
• To determine if the BRATS search included all relevant scientific literature.
• To assess whether the BRATS conclusions accurately reflect the evidence presented in the selected studies.

Main Methods:

• Replicated the literature search conducted by the BRATS authors.
• Critically analyzed the methods employed in the BRATS article.
• Compared the conclusions of the BRATS article with the results of the studies it cited.

Main Results:

• The BRATS search did not include all available scientific references on methylphenidate for ADHD.
• The BRATS article's conclusions contradict the findings of the studies it selected.
• The selected studies indicate that methylphenidate is safe and effective for ADHD treatment.

Conclusions:

• The BRATS article's conclusions are not supported by the evidence it reviewed.
• The BRATS article's findings are misleading and should not guide decisions on methylphenidate use for ADHD.
• A comprehensive and accurate assessment of scientific evidence is crucial for public health policy.